JACC Advances·22 AugEvent-Driven Intensification and Persistent Therapeutic Inertia in LDL-C Management Among 1,033,703 Patients With ASCVDStudy in peoplePopulationsPaper
AHA Scientific Sessions 2025 Abstract·3 NovLongitudinal LDL-C Control Among Patients With ASCVD and Elevated Baseline LDL-C: Insights From the cvMOBIUS-2 RegistryStudy in peoplePopulationsPaper